Moyle G, Gruber J, Dunbar M, Radtchenko J, et al. Outcomes in people with HIV who resume or switch to bictegravir/emtricitabine/tenofovir alafenamide following a treatment interruption. AIDS 2025 Mar 4. doi: 10.1097/QAD.0000000000004171.
PMID: 40053475